4-Sulfocalix[8]arene Hydrate
CAS: 137407-62-6
Ref. 3D-FS62102
10mg | Descatalogado | ||
25mg | Descatalogado | ||
50mg | Descatalogado | ||
100mg | Descatalogado | ||
250mg | Descatalogado |
Información del producto
- 4-Sulfonic Calix[8]Arene
- Calix(8)Arene-P-Sulfonic Acid
- 4-Sulfonic Calix[8]Arene 97%
- 4-Sulfocalix[8]arene (contains ca. 20% Water)
- 49,50,51,52,53,54,55,56-Octahydroxynonacyclo[43.3.1.1~3,7~.1~9,13~.1~15,19~.1~21,25~.1~27,31~.1~33,37~.1~39,43~]Hexapentaconta-1(49),3(56),4,6,9(55),10,12,15(54),16,18,21(53),22,24,27(52),28,30,33(51),34,36,39(50),40,42,45,47-Tetracosaene-5,11,17,23,29,35,41,47-Octasulfonic Acid
4-Sulfocalix[8]arene Hydrate is a polymeric matrix of sulfonated arenes that can be used to deliver enzymes for the treatment of diabetes. It has been shown to increase glucose uptake and decrease glycosylation of proteins, leading to improved insulin sensitivity in diabetic patients. 4-Sulfocalix[8]arene Hydrate is stable in the presence of strong acids and bases, allowing it to be administered orally. The diameter of the polymer can be tuned by changing the ratio between hydroxyl groups and sulfonated arenes. This property allows researchers to control the duration of enzyme release and improve its targeting properties. The polymer has also been shown to bind with fluorescence spectrometry, which may make it useful for detecting chemical reactions or identifying target tissue.